Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Deposit reference lists for 160 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact160 DOIs

Attach ORCID iDs across 142 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact142 DOIs

Add license metadata to 21 records

License metadata tells indexers and readers how each article may be reused.

Low impact21 DOIs

DOIs for this ISSN

Showing the top 5 of 239 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectabl… (10.20411/pai.v6i1.441)	References ORCID	102.85	113
2	Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Primi… (10.20411/pai.v6i1.408)	References ORCID	92.56	70
3	Antibiotics—From There to Where? (10.20411/pai.v3i1.231)	References ORCID	89.27	60
4	The intersection of COVID-19 and autoimmunity: What is our… (10.20411/pai.v6i1.417)	References ORCID	76.57	33
5	Soluble Markers of Immune Activation Differentially Normaliz… (10.20411/pai.v3i1.242)	References ORCID	74.57	30
6	Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to… (10.20411/pai.v4i1.269)	References ORCID	72.36	27
7	Evidence for Persistent Monocyte and Immune Dysregulation Af… (10.20411/pai.v4i2.336)	References ORCID	65.05	19
8	Plasma Extracellular Vesicle Subtypes May be Useful as Poten… (10.20411/pai.v6i1.384)	References ORCID	65.05	19
9	Antiretroviral Treatment for HIV Elite Controllers? (10.20411/pai.v5i1.364)	References ORCID	61.52	16
10	Characteristic Temporary Loss of Taste and Olfactory Senses… (10.20411/pai.v5i1.374)	References ORCID	60.21	15
11	Defining HIV and SIV Reservoirs in Lymphoid Tissues (10.20411/pai.v1i1.100)	References	59.95	249
12	Natural Killer Cell Diversity in Viral Infection: Why and Ho… (10.20411/pai.v1i1.142)	References ORCID	58.80	14
13	Long Non-Coding RNA-Mediated Regulation of the Interferon R… (10.20411/pai.v3i1.252)	References ORCID	57.31	13
14	Conversion and Reversion Rates of Tuberculosis Screening Ass… (10.20411/pai.v5i1.349)	References ORCID	57.31	13
15	Molecular Diagnosis of SARS-CoV-2: Assessing and Interpretin… (10.20411/pai.v6i1.422)	References ORCID	57.31	13
16	The Structure of the Membrane Protein of SARS-CoV-2 Resemble… (10.20411/pai.v5i1.377)	ORCID	53.34	135
17	The Critical Role of Nonhuman Primates in Medical Research -… (10.20411/pai.v2i3.186)	References	50.22	101
18	Fungal Diseases in the 21st Century: The Near and Far Horizo… (10.20411/pai.v3i2.249)	References	49.78	97
19	Effectiveness of Ultraviolet-C Light and a High-Level Disinf… (10.20411/pai.v5i1.372)	References	49.21	92
20	Interferons and HIV Infection: The Good, the Bad, and the Ug… (10.20411/pai.v1i1.125)	References	47.85	81
21	Pathogenesis of Aging and Age-related Comorbidities in Peopl… (10.20411/pai.v5i1.365)	References	47.02	75
22	COVID-19 Outcomes in Patients Undergoing B Cell Depletion Th… (10.20411/pai.v6i1.435)	References	46.88	74
23	Biomarkers of Cellular Stress Do Not Associate with sCD14 in… (10.20411/pai.v5i1.363)	References ORCID	45.15	7
24	Changes in the Serum Metabolome of Patients Treated With Bro… (10.20411/pai.v5i1.394)	References ORCID	45.15	7
25	Update on the Pathogenesis, Virulence, and Treatment of Cand… (10.20411/pai.v7i2.535)	ORCID	44.98	62
26	HIV Infection of Macrophages: Implications for Pathogenesis… (10.20411/pai.v2i2.204)	References	44.63	60
27	Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activi… (10.20411/pai.v2i2.200)	References	44.45	59
28	Hepatitis Delta Virus Detected in Salivary Glands of Sjögren… (10.20411/pai.v1i1.72)	References	43.90	56
29	Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the… (10.20411/pai.v6i2.460)	ORCID	42.69	50
30	Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From… (10.20411/pai.v10i1.752)	ORCID	42.47	49
31	Environmental Contamination with Candida Species in Multiple… (10.20411/pai.v4i2.291)	References	42.47	49
32	The TB27 Transcriptomic Model for Predicting Mycobacterium t… (10.20411/pai.v10i1.770)	References ORCID	38.91	5
33	Prospective Analysis of Lipid Composition Changes with Antir… (10.20411/pai.v2i3.218)	References	38.91	35
34	The Effects of Anti-retroviral Therapy on Epigenetic Age Acc… (10.20411/pai.v5i1.376)	ORCID	38.60	34
35	Crystal Structure and Immunogenicity of the DS-Cav1-Stabiliz… (10.20411/pai.v4i2.338)	References	38.29	33
36	Therapeutic Bacteriophages for Gram-Negative Bacterial Infec… (10.20411/pai.v7i2.516)	ORCID	38.29	33
37	A Cure for HIV Infection: “Not in My Lifetime” or “Just Arou… (10.20411/pai.v1i1.133)	References	37.96	32
38	ADCC-Mediated CD56dim NK Cell Responses Are Associated with… (10.20411/pai.v3i1.228)	References	37.96	32
39	Diminished CD103 (aEb7) Expression on Resident T cells from… (10.20411/pai.v1i2.166)	References	36.56	28
40	Evaluation of Ultraviolet-C Light for Rapid Decontamination… (10.20411/pai.v5i1.373)	References	36.56	28
41	Jak Inhibitors Modulate Production of Replication Competent… (10.20411/pai.v2i2.190)	References	36.18	27
42	Varicella Zoster Virus and Large Vessel Vasculitis, the Abse… (10.20411/pai.v2i2.196)	References	36.18	27
43	Elevated Circulating Concentrations of Interferon-Gamma in L… (10.20411/pai.v1i2.149)	References	35.37	25
44	Novel Strategies to Combat CMV-Related Cardiovascular Diseas… (10.20411/pai.v5i1.382)	ORCID	35.37	25
45	CD161 Expression on Mucosa-Associated Invariant T Cells is R… (10.20411/pai.v2i3.136)	References	34.04	22
46	Evaluation of Six Weekly Oral Fecal Microbiota Transplants i… (10.20411/pai.v5i1.388)	References	34.04	22
47	Clinical Application of Interferon-γ Release Assays for the… (10.20411/pai.v1i2.173)	References	33.06	20
48	α-Defensin HD5 Stabilizes Human Papillomavirus 16 Capsid/Cor… (10.20411/pai.v4i2.314)	References	33.06	20
49	Harnessing Bacterial Extracellular Vesicle Immune Effects fo… (10.20411/pai.v9i1.657)	ORCID	33.06	20
50	Increasing Rates of Fluoroquinolone Resistance in Escherichi… (10.20411/pai.v1i2.115)	References	32.53	19